Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-24 @ 2:28 PM
NCT ID:
NCT03572959
Eligibility Criteria:
Inclusion Criteria:
* histological diagnosis of OLP on the basis of WHO criteria (Meji and van der Waal 2003).
* presence of painful and atrophic-erosive oral lesions, unresponsive to topical corticosteroid therapy
* ability to complete the present clinical trial.
Exclusion Criteria:
* Presence of histological signs of dysplasia
* use of lichenoid reaction inducing drugs
* Therapy for OLP in the 2 months prior to the study;
* Patients suffering from any disease that may present with features similar to OLP (graft versus host disease or lupus erythematosus)
* Pregnant or lactating females
* Patients with uncontrolled diabetes or hypertension, positive HCV Ab or HBs Ag.
* Smokers
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
62 Years
Study:
NCT03572959
Study Brief:
Protocol Section:
NCT03572959